All products on this site are for research and development use only. More info CONTACT US

CJC-IPA Combo 10mg

$90.00

The CJC-IPA Combo is a blend of two peptides, CJC-1295 and Ipamorelin, which have been studied for their potential synergistic effects on growth hormone release. This combination is utilized in research to explore its impact on muscle growth, fat metabolism, and overall well-being.

Important Information About This Research Product:

  • Your vials are not empty; the product is at the bottom of the vial.
  • All peptides are provided in lyophilized (freeze-dried) powder form and must be reconstituted with bacteriostatic water (not provided).
  • Store in a cool, dry, dark place, away from UV rays. For best preservation, store at ≤ 4°C.
  • This product is intended for laboratory and research use only. No instructions on reconstitution or dosing can be provided.

Appearance

Lyophilized Powder

Synonyms

CJC-1295 and Ipamorelin Blend

Storage

Store all products in a dry, cool, and dark place away from UV rays. For best preservation, store at 4°C.

Description

The CJC-IPA Combo combines two peptides that have been the subject of extensive research:

  • CJC-1295: A synthetic analog of growth hormone-releasing hormone (GHRH), CJC-1295 is believed to stimulate the pituitary gland to increase the secretion of growth hormone (GH). Studies suggest that it may lead to elevated levels of GH and insulin-like growth factor 1 (IGF-1), which are associated with muscle growth and fat metabolism.
  • Ipamorelin: Classified as a growth hormone secretagogue, Ipamorelin is thought to promote the release of GH without significantly affecting other hormones like cortisol and prolactin. Research indicates that it may support muscle development and recovery.

When combined, these peptides are believed to have a synergistic effect, potentially enhancing the pulsatile and sustained release of growth hormone. This combination is utilized in research to investigate its effects on muscle growth, fat loss, and overall well-being.